Home
/
BioCardia, Inc.
/
Financials
/
Quarterly
BioCardia, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BioCardia, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$130.0K
Nov 9, 2017
Q2
2017
Jun 30, 2017
$112.0K
Aug 14, 2017
Q1
2017
Mar 31, 2017
$137.0K
May 11, 2017
Q3
2017
Sep 30, 2016
$117.0K
Nov 9, 2017
Q2
2017
Jun 30, 2016
$144.0K
Aug 14, 2017
Q1
2017
Mar 31, 2016
$178.0K
May 11, 2017
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2012
Sep 30, 2012
$19.0K
Nov 8, 2012
Q2
2012
Jun 30, 2012
$17.0K
Aug 10, 2012
Q1
2012
Mar 31, 2012
$11.0K
May 15, 2012
Q3
2011
Sep 30, 2011
$0
Nov 15, 2011
Q2
2011
Jun 30, 2011
$0
Aug 11, 2011
Q1
2012
Mar 31, 2011
$0
May 15, 2012
Q3
2011
Sep 30, 2010
$0
Nov 15, 2011
Q2
2011
Jun 30, 2010
$0
Aug 11, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.48M)
Nov 12, 2025
Q3
2025
Jun 30, 2025
($2.05M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($2.05M)
Oct 29, 2025
Q3
2025
Mar 31, 2025
($2.71M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($2.71M)
Oct 29, 2025
Q1
2025
Mar 31, 2025
($2.71M)
May 14, 2025
Q3
2025
Sep 30, 2024
($1.74M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
($1.65M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($1.65M)
Oct 29, 2025
Q3
2025
Mar 31, 2024
($2.27M)
Nov 12, 2025
Q2
2025
Mar 31, 2024
($2.27M)
Oct 29, 2025
Q1
2025
Mar 31, 2024
($2.27M)
May 14, 2025
Q3
2024
Sep 30, 2023
($2.57M)
Nov 13, 2024
Q3
2024
Jun 30, 2023
($3.42M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($3.42M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($3.50M)
May 14, 2024
Q2
2023
Mar 31, 2023
($3.50M)
Aug 9, 2023
Q3
2024
Mar 31, 2023
($3.50M)
Nov 13, 2024
Q3
2023
Sep 30, 2022
($3.06M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($2.50M)
Aug 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.49M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($2.05M)
Oct 29, 2025
Q1
2025
Mar 31, 2025
($2.73M)
May 14, 2025
Q3
2025
Sep 30, 2024
($1.76M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($1.65M)
Oct 29, 2025
Q1
2025
Mar 31, 2024
($2.28M)
May 14, 2025
Q3
2024
Sep 30, 2023
($2.60M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($3.45M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($3.51M)
May 14, 2024
Q3
2023
Sep 30, 2022
($3.06M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($2.50M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($3.33M)
May 10, 2023
Q3
2022
Sep 30, 2021
($2.71M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($3.49M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($2.97M)
May 11, 2022
Q3
2021
Sep 30, 2020
($3.85M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($3.57M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($4.61M)
May 13, 2021
Q3
2020
Sep 30, 2019
($3.23M)
Nov 10, 2020
Q2
2020
Jun 30, 2019
($3.76M)
Aug 13, 2020